Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program
2019 ◽
Vol 145
(12)
◽
pp. 3359-3369
◽
Keyword(s):
Keyword(s):
2017 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽